Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Prevnar trial results needed for CDC recommendation
Reuters
Wednesday, February 22, 2012 - 5:42pm
tags:
Prevnar 13, vaccines, CDC, pneumonia
Novartis' Rasilez to Carry Warning Novartis' Rasilez to Carry Warning
Yahoo/AP
Wednesday, February 22, 2012 - 5:36pm
tags:
Mylan, guidance
Teva Pays $250M To Settle Propofol Lawsuits
Pharmalot
Wednesday, February 22, 2012 - 11:47am
tags:
Teva Pharmaceuticals, settlements, propofol, anesthesia
Endo Pharmaceuticals Earnings Preview
Motley Fool
Wednesday, February 22, 2012 - 11:45am
tags:
earnings, Endo
J.&J. Offers Concessions to Win Approval for Synthes Deal
NY Times, NY
Wednesday, February 22, 2012 - 11:44am
tags:
JNJ, Synthes, M&A
Should doc-payment rules require more info?
Fierce Pharma
Wednesday, February 22, 2012 - 11:43am
tags:
Physician Payment Sunshine Act, physician payments
Pfizer reportedly weighing animal health IPO
Fierce Pharma
Wednesday, February 22, 2012 - 11:04am
tags:
IPO, Pfizer, animal health
The Cure for Alexion
TheStreet.com
Wednesday, February 22, 2012 - 11:02am
tags:
Alexion, PNH, Soliris
Forbes Earnings Preview: Dendreon
Forbes
Wednesday, February 22, 2012 - 11:01am
tags:
Dendreon, earnings
Human Genome Sciences Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Wednesday, February 22, 2012 - 11:01am
tags:
earnings, Human Genome Sciences
Jazz Pharmaceuticals Inc. Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Wednesday, February 22, 2012 - 11:00am
tags:
Jazz Pharmaceuticals, earnings
A Bio-Pharma Watch List For This Week: 4 Buys, 1 Sell
Seeking Alpha
Wednesday, February 22, 2012 - 11:00am
tags:
Antares, Bristol-Myers Squibb, Gilead, Indenix, Spectrum Pharmaceuticals
Medicines Co 4th-qtr profit beats Street
Reuters
Wednesday, February 22, 2012 - 10:58am
tags:
earnings, Medicines Company
Chelsea Therapeutics Drug Shouldn’t Be Approved, FDA Says
Bloomberg Businessweek
Wednesday, February 22, 2012 - 8:11am
tags:
FDA, Chelsea Therapeutics, Northera
Vivus: FDA Panel Live Blog
TheStreet.com
Wednesday, February 22, 2012 - 8:08am
tags:
FDA, Vivus, obesity, advisory panel, Qnexa
3 Biotech Takeover/LBO Potential Targets Being Snapped Up By Insiders
Seeking Alpha
Wednesday, February 22, 2012 - 8:07am
tags:
M&A, Seattle Genetics, Chelsea Therapeutics, Savient
Paying Attention to Biotech M&A Earnout Payments
Forbes
Wednesday, February 22, 2012 - 8:04am
tags:
M&A, Celgene, milestone payments, CovX, Pfizer, Ception Therapeutics, Gloucestor, Ovation, Salmedix, Agensys, Alnara, Adnexus, Atlas, Novexel, Cephalon
J&J CEO Succession: Who is Alex Gorsky?
WSJ Online
Tuesday, February 21, 2012 - 7:23pm
tags:
William Weldon, Alex Gorsky, JNJ, Pharma CEOs
ViroPharma Reports Encouraging Data
Yahoo/Zacks.com
Tuesday, February 21, 2012 - 7:21pm
tags:
ViroPharma, Plenadren, adrenal insufficiency
Opportunity In The Weight Loss Drug Market
Seeking Alpha
Tuesday, February 21, 2012 - 7:19pm
tags:
obesity, Vivus, Qnexa, Abbott Laboratories, Alkermes, GSK, JNJ, Roche, Orexigen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.